22
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Nocardiosis: updates and clinical overview.

      Mayo Clinic Proceedings
      Anti-Infective Agents, therapeutic use, Humans, Nocardia, drug effects, Nocardia Infections, diagnosis, drug therapy, microbiology, Risk Factors

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nocardia, a gram-positive bacillus with the microscopic appearance of branching hyphae, can produce considerable disease in the appropriate host. The taxonomy of Nocardia continues to evolve; more than 50 species have been described. Early recognition and effective therapy are imperative to achieve successful outcomes. Although nocardiosis typically occurs in patients with cell-mediated immunosuppressive conditions, infection may occasionally develop in immunocompetent patients as well. This review addresses the microbiology of Nocardia, risk factors for infection, clinical presentations, and management strategies. Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

          Related collections

          Author and article information

          Journal
          22469352
          3498414
          10.1016/j.mayocp.2011.11.016

          Chemistry
          Anti-Infective Agents,therapeutic use,Humans,Nocardia,drug effects,Nocardia Infections,diagnosis,drug therapy,microbiology,Risk Factors

          Comments

          Comment on this article